Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00944125 · ClinicalTrials.gov registry record · NA
Dual Site Left Ventricular (LV) Pacing
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00944125 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 50 participants.
The verdict
NCT00944125, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to compare Dual LV (left ventricular) pacing to standard single LV pacing (BiV pacing) to see if Dual LV pacing: 1. Improves the way the heart's left ventricle functions 2. Decreases the number of hospital and clinic visits for heart failure related symptoms 3. Slows the rate patients experience certain heart failure symptoms 4. Reduces uncoordinated heart contractions
Interventions
- DEVICE Dual Site LV Pacing
- DEVICE BiV Pacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00944125
The ClinicalTrials.gov registry entry for NCT00944125 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dual Site LV Pacing is the first listed.
NCT00944125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00944125 about?
NCT00944125 is a clinical study titled "Dual Site Left Ventricular (LV) Pacing". The purpose of this study is to compare Dual LV (left ventricular) pacing to standard single LV pacing (BiV pacing) to see if Dual LV pacing: 1. Improves the way the heart's left ventricle functions 2. Decreases the number of hospital and clinic visits for heart failure related symptoms 3. Slows th...
What is the current status of trial NCT00944125?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2009-06. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00944125?
The interventions under investigation include: Dual Site LV Pacing (DEVICE), BiV Pacing (DEVICE).
Who is sponsoring clinical trial NCT00944125?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.